“…In an attempt to rescue the cat enteroids, we supplemented 50% L-WRN CM with various factors that have been shown to induce enteroid growth in other platforms or to be secreted by mesenchymal/stromal cells within the crypt niche (Fig. 3) (Date and Sato, 2015; Roulis and Flavell, 2016). These factors included: ALK5 inhibitor A83-01 and p38 MAP kinase inhibitor SB202190 (Khalil et al, 2016; Sato et al, 2011a), human FGF-4 (Clevers, 2016; McCracken et al, 2014; Spence et al, 2011), human FGF-2 (FGF-basic) (Clevers, 2016), human FGF-10 and nicotinamide (Barker et al, 2010; Boj et al, 2015; Sato and Clevers, 2015), human IGF-I (Reynolds et al, 2014; Simmons et al, 2007), Prostaglandin E2 (PGE2) (Goessling et al, 2009; Jung et al, 2011; Pierzchalska et al, 2012), or mouse Wnt-2b and human Gremlin (Aoki et al, 2016; Stzepourginski et al, 2017).…”